A clinical study using a new approach for laparoscopic radical resection of Bismuth-Corlette Ⅲa hilar cholangiocarcinoma
10.3760/cma.j.cn113884-20220424-00185
- VernacularTitle:腹腔镜根治性切除Bismuth-Corlette Ⅲa型肝门部胆管癌新入路的临床应用分析
- Author:
Shubin ZHANG
1
;
Zixuan HU
;
Xinbo ZHOU
;
Zhongqiang XING
;
Weihong ZHAO
;
Jianhua LIU
Author Information
1. 河北医科大学第二医院肝胆外科，石家庄 050000
- Keywords:
Laparoscopy;
Klatskin tumor;
Bismuth-Corlette Ⅲa;
Orthotopic right hemihepatectomy;
Left-liver-first
- From:
Chinese Journal of Hepatobiliary Surgery
2022;28(11):827-830
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the safety and feasibility of laparosocpic left-liver-first anterior radical modular orthotopic right hemihepatectomy (Lap-Larmorh) in treatment of Bismuth-Corlette type Ⅲa hilar cholangiocarcinoma.Methods:From June 2020 to April 2022, 13 patients with Bismuth-Corlette type Ⅲa hilar cholangiocarcinoma underwent Lap-Larmorh at the Department of Hepatobiliary Surgery of the Second Hospital of Hebei Medical University. There were 8 males and 5 females, aged (60.9±8.4) years. The operation time, intraoperative blood loss, complications and postoperative survival were analyzed.Results:Five patients were treated with percutaneous transhepatic cholangial drainage to reduce jaundice before surgery. All 13 patients successfully underwent the Lap-Larmorh and there was no conversion to laparotomy. The operative time was [ M( Q1, Q3)] 390.0 (355.0, 435.0) minutes, and the intraoperative blood loss was [ M( Q1, Q3)] 800.0 (300.0, 1 100.0) ml. Postoperative complications occurred in 4 patients with pleural effusion, and 1 patient had portal vein thrombosis associated with pleural effusion, who was managed successfully using low molecular weight heparin sodium anticoagulation therapy and pleural effusion tapping. The postoperative hospital stay was (12.5±5.5) days, and there was no perioperative death. Intraoperative frozen pathology showed 12 patients with left hepatic duct with negative margins, and 1 patient with moderate dysplasia. Postoperative paraffin pathology showed 12 patients with bile duct adenocarcinoma, 1 patient with bile duct mucinous adenocarcinoma, 2 patients with tumors of high differentiation, 10 patients with moderate differentiation, and 1 patient with poor differentiative. The R 0 resection rate was 100.0% (13/13) and the tumor diameter was (2.9±0.9) cm. Follow-up by telephone or outpatient clinics after operation showed 1 patients to be lost to follow-up. The 1-year survival rate after operation was 66.7% (8/12). Conclusion:For Bismuth-Corlette type Ⅲa hilar cholangiocarcinoma, the new laparoscopic approach of Lap-Larmorh was safe and feasible.
